BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33080779)

  • 1. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
    Bewersdorf JP; Zeidan AM
    Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
    Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
    Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
    Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
    Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
    Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
    Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperleukocytosis in Acute Myeloid Leukemia: Considerations for Inpatient Diagnosis and Management.
    Wheatley TT; Foster Castiglione H; Phong K; Yoon M
    Clin J Oncol Nurs; 2023 Nov; 27(6):589-593. PubMed ID: 38009885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperleukocytosis and leukostasis: management of a medical emergency.
    Giammarco S; Chiusolo P; Piccirillo N; Di Giovanni A; Metafuni E; Laurenti L; Sica S; Pagano L
    Expert Rev Hematol; 2017 Feb; 10(2):147-154. PubMed ID: 27967252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis.
    Zhao J; Bewersdorf JP; Jaszczur S; Kowalski A; Perreault S; Schiffer M; Gore S; Podoltsev N; Prebet T; Shallis R; Zeidan AM
    Leuk Lymphoma; 2021 May; 62(5):1195-1202. PubMed ID: 33325761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytoreduction for acute leukemia.
    Porcu P; Farag S; Marcucci G; Cataland SR; Kennedy MS; Bissell M
    Ther Apher; 2002 Feb; 6(1):15-23. PubMed ID: 11886572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
    Korkmaz S
    Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperleukocytosis, leukostasis and leukapheresis: practice management.
    Ganzel C; Becker J; Mintz PD; Lazarus HM; Rowe JM
    Blood Rev; 2012 May; 26(3):117-22. PubMed ID: 22364832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Leukocytapheresis to relieve priapism due to leukostasis in CML patients: Our experience in a tertiary care centre.
    Sil S; Mohan AK; Negi G; Banerjee P; Kaur D; Mittal A; Jain A
    Transfus Clin Biol; 2024 Feb; 31(1):36-40. PubMed ID: 37944664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperleukocytosis and leukostasis in acute and chronic leukemias.
    Macaron W; Sargsyan Z; Short NJ
    Leuk Lymphoma; 2022 Aug; 63(8):1780-1791. PubMed ID: 35357988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Hyperleukocytosis in Childhood Acute Leukemia Without Leukapheresis and Rasburicase Prophylaxis.
    Aylan Gelen S; Sarper N; Zengin E; Azizoğlu M
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):12-18. PubMed ID: 34054042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis.
    Creutzig U; Rössig C; Dworzak M; Stary J; von Stackelberg A; Wössmann W; Zimmermann M; Reinhardt D
    Pediatr Blood Cancer; 2016 Apr; 63(4):640-5. PubMed ID: 26670831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukostasis in Chronic Lymphocytic Leukemia.
    Singh N; Singh Lubana S; Dabrowski L; Sidhu G
    Am J Case Rep; 2020 Jul; 21():e924798. PubMed ID: 32616708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Myeloid Leukemia Complicated by Hyperleukocytosis and Leukostasis in the Emergency Department.
    Ngo RT; Webb McAdams AL; Furiato A
    Cureus; 2021 Jun; 13(6):e15392. PubMed ID: 34094792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
    Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
    Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis.
    Cline A; Jajosky R; Shikle J; Bollag R
    J Clin Apher; 2018 Jun; 33(3):396-400. PubMed ID: 28940295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study.
    Rinaldi I; Sari RM; Tedhy VU; Winston K
    J Blood Med; 2021; 12():623-633. PubMed ID: 34290537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.